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Abstract
CREB mediates the transcriptional effects of glucose and incretin hormones in insulin-target cells and insulin-producing b-
cells. Although the inhibition of CREB activity is known to decrease the b-cell mass, it is still unknown what factors inversely
alter the CREB signaling pathway in b-cells. Here, we show that b-cell dysfunctions occurring in chronic hyperglycemia are
not caused by simple inhibition of CREB activity but rather by the persistent activation of CREB due to decreases in protein
phophatase PP2A. When freshly isolated rat pancreatic islets were chronically exposed to 25 mM (high) glucose, the PP2A
activity was reduced with a concomitant increase in active pCREB. Brief challenges with 15 mM glucose or 30 mM forskolin
after 2 hour fasting further increased the level of pCREB and consequently induced the persistent expression of ICER. The
excessively produced ICER was sufficient to repress the transcription of NeuroD, insulin, and SUR1 genes. In contrast, when
islets were grown in 5 mM (low) glucose, CREB was transiently activated in response to glucose or forskolin stimuli. Thus,
ICER expression was transient and insufficient to repress those target genes. Importantly, overexpression of PP2A reversed
the adverse effects of chronic hyperglycemia and successfully restored the transient activation of CREB and ICER.
Conversely, depletion of PP2A with siRNA was sufficient to disrupt the negative feedback regulation of CREB and induce
hyperglycemic phenotypes even under low glucose conditions. Our findings suggest that the failure of the negative
feedback regulation of CREB is the primary cause for b-cell dysfunctions under conditions of pathogenic hyperglycemia, and
PP2A can be a novel target for future therapies aiming to protect b-cells mass in the late transitional phase of non-insulin
dependent type 2 diabetes (NIDDM).
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Introduction
Glucose has a critical influence on b-cell functions and mass.
Transient increases in glucose concentration within the physio-
logical range promote insulin biosynthesis and secretion. Chronic
elevation of glucose level, however, exerts adverse effects on b-cells
and leads to decreases in b-cell survival and b-cell-enriched gene
expression; the phenomenon is termed ‘‘glucotoxicity’’. Thus,
preservation of b-cell mass against glucotoxicity has become a
major point of research in type 2 diabetes. Extensive studies have
revealed that chronic hyperglycemic environment imposes various
types of stress on b-cells including oxidative stress, endoplasmic
reticulum stress, cytokine-induced apoptosis, and hypoxia [1].
However, it is not yet clear how those stress progressively leads to
defects in insulin gene synthesis/secretion, and the loss of
functional b-cell mass.
Insulin gene expression is regulated by the combined actions
of b-cell-specific transcription factors that are also required for
the development and survival of pancreatic islet cells. These
factors include Pdx-1/IPF-1, Pax4, Pax6, NeuroD/BETA2,
Nkx2.2, and MafA [2,3]. In particular, NeuroD/BETA2, a
basic helix-loop-helix transcription factor,d i r e c t l yr e g u l a t e s
insulin gene transcription [4], also regulates b-cell-specific genes
that are necessary for glucose hom e o s t a s i ss u c ha ss u l f o n y l u r e a
receptor I (SUR1) [5]. NeuroD-deficient mice die at early ages
due to severe diabetes [6], or if they survive to adulthood in a
different genetic background, b-cells remain immature and lose
functional glucose-responsiveness [7]. Transduction of the
NeuroD protein can alleviate diabetic symptoms in a type 1
diabetic mouse model [8]. In humans, mutations in NeuroD can
predispose individuals to develop maturity onset diabetes of the
y o u n g( M O D Y )[ 9 ] .G i v e nac r i t i c a lr o l eo fN e u r o Di nt h e
developing pancreatic islet cells and in mature b-cells, efforts
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effectively treat diabetes mellitus.
cAMP response element binding protein (CREB) is known to
play a key role in maintaining glucose homeostasis by mediating
the transcriptional effects of glucose and incretin hormones [10].
The functions of CREB have been mostly characterized in
association with its cofactor, CRTC2, in the process of fasting-
associated gluconeogenesis in insulin-target tissues such as liver
and skeletal muscle [11]. By comparison, the roles of CREB in
insulin producing b-cells are relatively unknown except that
inhibition of CREB in transgenic mice with a dominant negative
A-CREB causes severe hyperglycemia due to the loss of b-cell
mass [12]. Although those data indicate that CREB is important
for preservation of functional b-cell mass, it is still unknown
what factors inversely alter the CREB signaling pathway in b-
cells.
CREB is activated by phosphorylation at Ser133 in response to
increases in intracellular levels of Ca
2+ or cAMP but deactivated
by dephosphorylation of Ser133 by Ser/Thr protein phosphatases,
including PP1, PP2A, and PP2B/calcineurin [10,13]. These
phosphatases play diverse roles in various cell types, including b-
cells [14]. Clinical and ethnographical studies with Pima Indians
also have suggested that defects in PP1 and PP2A are associated
with diabetes [15–18]. Sato et al., 1998 [19] have showed that
okadaic acid, a universal inhibitor of Ser/Thr phosphatases,
inhibits insulin secretion by disrupting Ca
2+ signaling. Depletion of
PP2A catalytic subunits using small interfering RNA markedly
attenuates glucose-stimulated insulin secretion from pancreatic b-
cells [20]. Given that Ser/Thr protein phosphatases have broad
substrate specificity, it is predictable that their modulation may
affect glucose homeostasis in similar ways. However, mice either
lacking or overexpressing PP2B/calcineurin in b-cells ironically
display similar diabetic symptoms [21,22], while PP2A null mice
are embryonically lethal [23]. Thus, the precise functions of
protein phosphatases are yet to be determined with respect to b-
cell functions or diabetes.
CREB signals can be terminated via a negative feedback control
by ICER (inducible cAMP early repressor) [24]. ICER mRNA is
generated from the CRE-containing intronic P2 promoter of the
cAMP response element modulator (CREM) gene, a closely
related in structure to CREB, in response to accumulation of
active pCREB. ICER proteins dimerize with CREB or CREM
activators, and the dimers, in turn, switch off CRE-mediated gene
expression including ICER itself. In b-cells, insulin is known as a
direct target of ICER [25]. ICER expression is elevated in
hyperglycemic rodent islets [26–28]. Transgenic mice overex-
pressing ICER in pancreatic b-cells exhibit severe diabetic
symptoms at early ages because of a decrease in b-cell mass
[29]. Because insulin deficiency cannot fully ascribe for the loss of
b-cell mass at early ages, other factors that regulate differentiation
and survival of b-cells may be involved.
In the present study, using freshly isolated rat islet cells as an ex
vivo system that allows molecular-level studies under physiological
and pathophysiological conditions (normoglycemica versus hyper-
glycemia), we show that the decreased level of PP2A levels and the
consequent upregulation of ICER is the primary cause for the
failure of the negative feedback regulation of CREB under chronic
hyperglycemic conditions. We also show that the deregulation of
CREB signaling pathway is a key mechanism for silencing of b-cell
specific genes such as NeuroD and insulin in the progression of b-
cell failure as a complication of diabetes.
Results
Chronic exposure to high glucose prolongs ICER
expression in hyperglycemic islets
To establish a cellular glucotoxicity model, rat pancreatic islets
were freshly isolated and grown in RPMI medium containing
30 mM (high level) or 5 mM (low level) glucose for 8 days
(Figure 1A). To validate 8-day cultivation in 30 mM glucose could
mimic chronic hyperglycemia in vivo, we tested insulin secretion
capability. In low glucose conditions, the islets retained the original
aggregated morphology (Figure 1B) as well as the capability to
secrete insulin in response to acute challenges with 15 mM glucose
following 2 h-fasting in 5 mM glucose (Figure 1C). In contrast, 8-
day cultivation in the presence of 30 mM glucose blunted glucose-
stimulated insulin secretion. Concomitantly, the total insulin
content in the islets was also reduced after 8-day cultivation in
30 mM glucose (Figure 1C). Decrease in insulin secretion and
insulin content are the indication of glucotoxicity found in chronic
hyperglycemia [1]. Hence, the experimental condition described
in Figure 1A provides a proper cellular glucotoxicity model for the
analysis of impaired b-cell specific gene expression. The total RNA
was isolated from each of 30 islets and the expression levels of b-
cell specific genes were quantitated using SYBR green real-time
PCR (Supporting Table S1). When islets were cultivated in the
presence of 5 mM glucose, acute stimulus with 15 mM glucose
slightly increased the mRNA levels of NeuroD and SUR1 within
6 hours whereas the insulin transcription was not altered
(Figure 1E–1G). Importantly, ICER expression was transiently
increased by 3.8-fold at 2 h but fell to the basal level at 6 h
(Figure 1D). In contrast, when islets were cultivated in the
presence of 30 mM glucose, the insulin transcription was reduced
by 58% (Figure 1G). Concomitantly, the mRNA levels of NeuroD,
SUR1, and insulin were reduced by 86%, 72%, and 81% after
6 hour challenge with 15 mM glucose, respectively (Figure 1E–
1G). Importantly, the mRNA level of ICER was persistently
elevated in 30 mM glucose and further increased by 15 mM
glucose stimulus up to 9.3 folds for 6 hours (Figure 1D).
Meanwhile, the mRNA level of Pdx-1 was not altered in any
instance (Figure 1H), consistent with the notion that the regulation
of Pdx-1 mainly takes place at the post-transcriptional level [30–
32]. The results also suggest that the reduced intracellular insulin
content in chronic hyperglycemia (Figure 1C) are partially due to
the decrease in insulin gene transcription (Figure 1G). Traditional,
semi-quantitative RT-PCR data performed with HIT cells were
also similar to those obtained with SYBR green real-time PCR
(Supporting Figure S1). Taken together, these results suggest that
chronic exposure to hyperglycemia prolongs the ICER induction.
The inverse correlation of ICER with NeuroD, SUR1 and insulin
also suggest that these genes may be directly or indirectly regulated
by ICER.
Excessive activation of CREB prolongs ICER induction
Since ICER is known to be induced by excessive activation of
the cAMP-CREB pathway [24], chronic hyperglycemia may also
alter the b-cell specific gene expression in response to hormones
that increase the intracellular cAMP levels. To mimic hormonal
effects, we added 30 mM forskolin, an activator of adenylyl cyclase,
to islet cultures that were maintained in 5 mM or 30 mM glucose
for 8 days (Figure 2A). The responsiveness to cAMP was
maintained in islet cells cultured in low glucose conditions for 8
days, thus the levels of NeuroD, SUR1, and insulin mRNA were
increased for 6–12 h after forskolin treatment (Figure 2C–2E).
Importantly, ICER was transiently induced only for 6 h and the
ICER level dropped to the basal level at 12 h (Figure 2B). In
ICER-Mediated NeuroD Repression in Hyperglycemia
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e34860Figure 1. Chronic hyperglycemia alters the b-cell specific gene expression in pancreatic islets. (A) Rat islet cells were cultured in the
presence of 5 mM or 30 mM glucose for 8 days, and stimulated with 15 mM glucose for 0–6 h after 2 h preconditioning in 5 mM glucose. (B)
Dithizone staining of islet cells after 8 days of culture. Scale bar: 100 mm. (C) In low (5 mM) glucose condition, insulin secretion was normal in
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treatment with forskolin increased the ICER transcription for an
extended period of time up to 12 h. Under the same condition, the
mRNA levels of NeuroD, SUR1, and insulin were reduced by
forskolin (Figure 2C–2E). As expected, the transcription of Pdx-1
was not altered (Figure 2F). The results suggest that the impaired
gene expression of b-cell specific genes in response to glucose or
forskolin (or cAMP) after chronic exposure to hyperglycemia may
involve common signaling pathways.
To understand the molecular mechanisms underlying the
distinctive responsiveness to glucose or hormonal stimuli after
long-term culture in high and low glucose, we sought for another
in vitro culture system that could recapitulate the long-term effects
of glucose as found in pancreatic islet cells while allowing us to
manipulate gene expression. HIT insulinoma cells were grown in
DMEM containing 5.5 mM (low) and 25 mM (high) glucose. As
traditional, semi-quantitative RT-PCR and real-time PCR with
SYBR green yielded qualitatively similar results in islet cells
(compare Figures 1 and 2 with Supporting Figures S1 and S2),
traditional RT-PCR analysis was carried out to investigate the
impaired gene expression. In HIT cells, the responsiveness to
cAMP was impaired as found in rat islet cells grown in high
glucose (Figure 2 and 3). Thus, forskolin prolonged the ICER
induction for longer than 6 h and concomitantly suppressed the
level of NeuroD, SUR1, and insulin transcription by 77%, 54%,
and 72%, respectively (Figure 3). In contrast, in HIT cells grown in
the presence of 5.5 mM (low) glucose, ICER was transiently
induced only for 1 h after forskolin treatment but immediately fell
to the basal level thereafter. Meanwhile, the expression of
NeuroD, insulin, or SUR1 was not affected. The data consistently
suggest that persistent induction of ICER is the primary cause for
the repression of NeuroD, SUR1, and insulin. The results also
indicate that HIT cells can serve as a physiologically relevant in
vitro system for analyzing the effects of chronic hyperglycemia on
ICER-mediated repression of b-cell-specific genes. As NeuroD is a
known transcriptional regulator of SUR1 and insulin, we
hypothesized that NeuroD might be a direct target of ICER.
NeuroD is a target gene of ICER
The mouse NeuroD gene [33] contains a TATA box in the
proximal promoter and two putative canonical CRE-like sequenc-
es (TCAGCT
C/A
A/G)a t21001 bp and 273 bp, with reference
to the transcription initiation site (Figure 4A). Only the CRE-like
sequence at 273 bp is highly conserved among humans, primates,
and rodents (Supporting Table S2), suggesting the retention of
functional significance throughout evolution.
To determine whether the CRE-like sequence at 273 bp
functions as a binding site for ICER, we performed assays with
reporter genes driven by the full length, pGL3-NeuroD(22.2 kb),
and minimum promoter, pGL3-NeuroD(2100 bp) (Figure 4B).
The 2.2 kb fragment upstream from the transcriptional startpoint
is known to be sufficient to direct b-cell-specific expression of
NeuroD [34], whereas the 100 bp fragment contains minimal
promoter with TATA box and a putative CRE sequence.
Overexpression of CREB enhanced the promoter activities of
pGL3-NeuroD(22.2 kb) and pGL3-NeuroD(2100 bp) by
4.1,6.9-fold in HIT cells (Figure 4C). Importantly, both the
basal and CREB-stimulated activity of reporter genes with wild
type CRE were downregulated by forskolin treatment (Figure 4C).
Overexpression of ICER Ic repressed the both reporter genes in a
dose-dependent manner (Figure 4D) whereas overexpression of
CREMta, a constitutively active form of CREM that has a higher
affinity for CRE sequences than CREB [25,35], attenuated the
negative effects of ICER by competing with ICER for binding to
the CRE sequence (Figure 4E). In any cases, a mutation of the
CRE sequence (mCRE) abolished the effects of CREB, CREMta,
ICER Ic, or forskolin, verifying the idea that the TCAGCTCA
sequence at 273 bp is a functional CRE. Direct binding of ICER
to the CRE at the 273 bp position was clearly proven by
chromatin immunoprecipitation (ChIP) assays performed with an
anti-ICER antibody (Figure 4F). Under low glucose conditions,
the amount of the ICER-specific product was minor and not
increased by forskolin. In contrast, the basal intensity of ChIP
product was slightly elevated under high glucose conditions and
further increased by 2.3-fold at 6 h after the forskolin treatment.
These data collectively suggest that chronic exposure to supra-
physiologic glucose concentrations destroys the negative feedback
regulation of the CREB-ICER pathway and the excessively
produced ICER proteins silence the NeuroD promoter by binding
to the CRE.
Deregulation of CREB signaling by reduced PP2A in
chronic hyperglycemia
ICER expression can be terminated by deactivation of pCREB
which otherwise binds to a CRE site in the ICER promoter, and
by autologous negative feedback by its own product [24]. Thus,
persistent induction of ICER in chronic hyperglycemia suggests
that pCREB deactivation does not occur and consequently the
pCREB level is constantly elevated. Indeed, western blot analysis
indicated that pCREB expression under low glucose conditions
was minimal and transiently increased by 1.4-fold only for 30 min
after forskolin treatment (Figure 5). By comparison, the basal
pCREB level was elevated by 1.4-fold under high glucose
conditions, and further increased by forskolin. The elevation of
pCREB level longer than 3 h was sufficient to support the
persistent ICER induction for an extended period of time.
To estimate the deactivation pathway of pCREB, we firstly
identified Ser/Thr protein phosphatases responsible for dephos-
phorylation of CREB Ser133 by RT-PCR analysis of protein
phosphatases that were previously found in b-cells [14]. Among
the catalytic subunit of PP1, PP2A, and PP2B/calcineurin, we
found that only the PP2A expression was downregulated more
than 50% in pancreatic islets after chronic exposure to high
glucose (Figure 6A and 6B). Under the same condition, PP1 or
PP2B/calcineurin was not affected at all. Similarly, the protein
levels of PP1a and calcineurin/PP2Ba were not reduced in HIT
cells (Figure 6C) under the condition that the PP2A protein level
was decreased (Figure 6D). The data indicate that PP2A is the
major protein phosphatase that is downregulated by chronic
response to acute stimulation with 15 mM glucose after 8 day culture whereas insulin secretion was impaired after 8-day exposure to high (30 mM)
glucose. Under high glucose conditions, cellular insulin content were significantly reduced, and total proteins were decreased slightly. (D,H) Real-
time PCR was carried out using SYBR green to quantitate the mRNA levels of indicated genes in diverse conditions shown in A. Relative mRNA levels
were estimated from of Ct values summarized in Supporting Table S1 using 2
2DDCt method. The data from three independent experiments are
presented as average fold ratios (means 6 S.E.) of relative mRNA expression compare with the 5 mM glucose-cultured islets before glucose
stimulation. Simultaneous decreases in the mRNA levels and the intracellular insulin content correlated well. Significant effects of 15 mM glucose
(*, P,0.05; **, P,0.01) or 8-day incubation in 30 mM glucose (
#, P,0.05) are marked. Similar results were obtained with traditional, semi-quantitative
methods (Supporting Figure S1).
doi:10.1371/journal.pone.0034860.g001
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activity of PP2A was also decreased after chronic exposure to high
glucose (Figure 6E), being consistent with the persistent elevation
of pCREB or ICER expression. Thus, moderate overexpression of
the PP2A Ca (0.05–0.1 mg) negated the inhibitory effects of
forskolin and restored the CREB-mediated induction of the
NeuroD promoter to the value in the absence of forskolin
(Figure 6F). By comparison, excessive expression of PP2A Ca
(0.15 mg) lowered the CREB-mediated induction of the NeuroD
probably by abrogating even the beneficial effect of pCREB
(Figure 6F). When HIT cells were grown in 5.5 mM glucose, acute
challenges with 15 mM glucose or 30 mM forskolin did not
significantly alter the levels of PP2A Ca mRNA, protein, and
enzyme activity for 6 h. The results collectively suggest that the
PP2A activity predisposed by long-term culture (low versus high
glucose conditions) is a determinant for the basal pCREB level and
the subsequent duration of ICER induction (transient versus
persistent) in response to acute stimulation with glucose or
forskolin.
Reduced activity of PP2A is the primary cause of
impaired gene expression
We hypothesized that simple depletion of PP2A under low
glucose conditions would mimic hyperglycemic condition and
evoke responses of chronic hyperglycemia by forskolin treatment.
Figure 2. Chronic hyperglycemia alters the responsiveness to cAMP in pancreatic islets. (A) Rat islet cells were cultured in the presence of
5 mM or 30 mM glucose for 8 days and stimulated with 30 mM forskolin for 0–12 h after 2 h preconditioning in 5 mM glucose. (B,F) Real-time PCR
was carried out using SYBR green to quantitate the mRNA levels of indicated genes in diverse conditions shown in A. Relative mRNA levels were
estimated from Ct values summarized in Supporting Table S1 using 2
2DDCt method. The data from three independent experiments are presented as
average fold ratios of relative mRNA expression compare with the 5 mM glucose-cultured islets before forskolin treatment in 5 mM glucose-cultured
islets. Significant effects of forskolin (*, P,0.05; **, P,0.01) or 8-day incubation in 30 mM glucose (
#, P,0.05) are marked.
doi:10.1371/journal.pone.0034860.g002
ICER-Mediated NeuroD Repression in Hyperglycemia
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34860The siRNA was designed to target PP2A Ca that is highly
conserved among species [36] including hamster-derived HIT cells
(Supporting Figure S3). Depletion of PP2A Ca was verified by
RT-PCR and western analysis (Figure 7A). In HIT cells
transfected with PP2A Ca-specific siRNA, pCREB level was
persistently enhanced in the presence of 5.5 mM glucose
regardless of forskolin treatment (Figure 7B). Concomitantly,
ICER was persistently expressed while expressions of NeuroD,
SUR1, and insulin were repressed (Figure 7C and 7D). In contrast,
stable expression of PP2A Ca prevented the excessive production
of ICER and thus, the expression of NeuroD, SUR1, and insulin
remained unaffected by forskolin treatment even after long-term
culture in 25 mM glucose (Figure 7E and 7F). The results
collectively indicate that PP2A is an important player that
determines the basal pCREB level and the duration of ICER
induction in response to various glucose concentrations, conse-
quently influencing the expression of b-cell-specific genes.
Discussion
Over the years, knowledge on the mechanisms underlying
chronic hyperglycemia-induced glucotoxicity has expanded rap-
idly, and several candidate components possibly associated with
pathogenesis in pancreatic b-cells have been identified. Here, we
describe a novel function of PP2A; the phosphatase switches the
stimulatory signals of glucose or cAMP to a repressive mode
during the pathogenic progress culminating in b-cell dysfunction
and failure.
Under normoglycemic conditions, acute elevation of extracel-
lular glucose and intracellular cAMP levels stimulate NeuroD
expression, whereas the same stimuli are interpreted as repressive
signals under hyperglycemic conditions (Figure 1E and 2C). This
divergent response is determined by the tonic level of pCREB and
the continuance of ICER expression. In the absence of a
deactivation pathway operated by PP2A under chronic hypergly-
cemia, CREB remains constantly activated, and further stimula-
tion by glucose or forskolin above a physiological threshold
prolongs the expression of a negative regulator ICER. Excessive
production of ICER proteins in turn leads to repression of the
NeuroD promoter. As insulin transcription is negatively regulated
by ICER [25] and positively by NeuroD [4] the insulin synthesis/
expression can be influenced directly by ICER [25] and indirectly
through ICER-mediated NeuroD silencing (Figure 8).
As mentioned above, NeuroD is essential for the normal
development, functional maturation of pancreatic b-cells, and
maintenance of pancreatic b-cell physiology [37,38]. NeuroD
regulates the expression of other factors critical in glucose sensing
and insulin exocytosis. These proteins include glucokinase
(hexokinase IV), a rate-limiting enzyme of glucose metabolism
[39]; the islet-specific glucose-6-phosphatase catalytic subunit-
related protein [40]; secretin [41]; Pax6 [42]; SUR1, the
regulatory subunit of the ATP-sensitive K
+ channel [5]; SNAP25;
syntaxin1A [43]; piccolo; and Noc2 [7]. Therefore, downregula-
tion of NeuroD in chronic hyperglycemia may not only decrease
insulin transcription but also attenuate insulin secretion [43] by
affecting the glucose sensing and insulin exocytosis machinery.
Taken together, ICER-mediated repression of NeuroD synthesis
under hyperglycemic conditions may be a critical pathogenic
process leading to the impaired insulin depletion, secretion
(Figure 8).
In experiments performed under high glucose conditions, the
CREs of ICER and NeuroD consistently responded to glucose or
cAMP signals in the opposite ways such that ICER was
upregulated while NeuroD was repressed both in islets and HIT
cells (Figures 1–3). The opposite responses of CREs are possibly
attributable to the several facts. First, the CRE of the ICER gene is
activated by the active pCREB in the early phase after forskolin
stimulus, whereas the CRE of NeuroD is influenced by the ratio of
repressors to activators (ICER:pCREB or ICER:CREM) in the
late phase [44]. The ICER:CREM ratio is similarly shown to be a
key regulator for homeostatic expression of pineal hormones such
as melatonin in accordance with circadian rhythm in neuroendo-
crine cells [45,46]. Second, diverse flanking sequences around
CREs may display differential affinities for ICER, CREB, and
CREM [25,47]. Finally, the contribution of CREB signals to the
NeuroD gene may be less than that of ICER, because NeuroD
transcription is cooperatively regulated by several factors,
including Ngn3 [34] and CREB (Figure 4), whereas ICER is
solely regulated by CREB.
Ser/Thr protein phosphatases share substrates but differ in
terms of metal ion requirement. Specifically, PP2A does not
contain metal ions, whereas PP2B/calcineurin requires Ca
2+ ions
Figure 3. cAMP exerts similar effects in HIT cells after chronic
exposure to hyperglycemia. (A) HIT cells were grown in 5.5 mM (left
panels) or 25 mM glucose (right panels) and treated with 30 mM
forskolin for the indicated time. Semi-quantitative RT-PCR analysis
revealed a transient (in 5.5 mM glucose) or a persistent (in 25 mM
glucose) induction of two isoforms of ICER. (B) The mRNA level of each
gene was normalized to that of GAPDH. Data from three independent
experiments are presented as fold ratios with respect to the value
obtained with 5.5 mM glucose in the absence of forskolin. Significant
effects of forskolin (*, P,0.05; **, P,0.01) or chronic 25 mM glucose
(
#, P,0.05;
##, P,0.01) are marked.
doi:10.1371/journal.pone.0034860.g003
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34860Figure 4. ICER binds to a novel CRE sequence in the proximal NeuroD promoter. (A) Comparison of the proximal promoters of mouse
(gi:3641530) and human (gi:7416051) NeuroD. The mouse TATA box (NNNN)a t230 bp and a potential CRE site (****) at 273 bp from the
transcription initiation site (the arrow) are conserved. (B) A schematic model of reporter genes with 2100 bp or 22.2 kb fragment of NeuroD
promoter. Sequences for a putative wild type CRE and mutated (mCRE) are shown. (C) Reporter genes with the wild type CRE or mCRE (0.4 mg) were
cotransfected with the CREB expression vector (0.15 mg) into HIT cells grown in 25 mM glucose. Forskolin (30 mM) was added for the indicated time
before harvesting. The average luciferase activity from three independent experiments was shown as the fold ratio with respect to the basal activity
of the reporter gene without CREB overexpression and forskolin. (*, P,0.05; **, P,0.01). (D) ICER Ic directly repressed in a dose dependent manner
the NeuroD reporter genes (0.4 mg) only with the wild type CRE but not with a mCRE in HIT cells grown in 5.5 mM glucose. (E) HIT cells grown in
5.5 mM glucose were cotransfected with NeuroD reporter genes (0.4 mg) and expression vectors for CREM ta (0.4 mg) and/or ICER Ic (0.1 mg). The
relative luciferase activity from three independent experiments is presented as the fold ratio with respect to the value of indicated conditions. (F)
ChIP assays were performed to detect direct binding of endogenous ICER to the NeuroD CRE sequence at 273 bp using HIT cells grown in 5.5 mM or
ICER-Mediated NeuroD Repression in Hyperglycemia
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34860for optimal activity [48]. In the present study, we showed that
PP2A is the key regulator that keeps the pCREB level below the
physiological threshold under normoglycemic conditions. Howev-
er, we cannot exclude the possibility that other Ser/Thr
phosphatases, such as PP1 and PP2B/calcineurin, also play roles
in pancreatic islets or b-cells. Indeed, several lines of evidence
suggest associations of PP1, PP2A, and PP2B/calcineurin
expression levels with diabetes in human patients. As mentioned
above, earlier ethnographic studies have found that defective PP1
is a risk factor for non-insulin dependent diabetes mellitus
(NIDDM) in Pima Indians of the southwest United States [18].
Clinical studies further have revealed that both PP1 and PP2A are
decreased in the skeletal muscle of patients with NIDDM [15–17].
Depletion of the PP2A catalytic subunit markedly attenuates
glucose-stimulated insulin secretion from pancreatic b-cells [20].
As PP2A knockout is embryonically lethal in mice [23], the role of
PP2A in pathogenesis of diabetes remains to be determined.
Interestingly, transgenic mice harboring a defective PP2A gene has
been utilized as a model of Alzheimer’s disease [49], suggesting
that a common pathway is operative in neurons and pancreatic b-
cells (see below). Inhibitors of PP2B/calcineurin, including FK506
and cyclosporin A, suppressed insulin mRNA level as well as
insulin secretion in isolated pancreatic islets and b-cell lines
[50,51]. Targeted deletion of PP2B in pancreatic b-cells induces
age-dependent diabetes characterized by decreased b-cell prolif-
eration and reduced b-cell mass with concomitant decreases in the
levels of b-cell transcription factors including MafA, Pdx-1, and
NeuroD [21]. Paradoxically, transgenic mice overexpressing PP2B
in b-cells also display diabetic symptoms with reduced b-cell mass
[22]. Thus, fine control of Ser/Thr phosphatase levels may be
crucial for maintenance of b-cell functions and mass [52]. Under
our experimental conditions, the effect of PP1 and PP2B was
minor compared to that of PP2A in HIT cells (Figure 6), possibly
because of variations in the in vitro culture conditions used to grow/
maintain pancreatic b-cells and insulinoma cells.
CREB functions as a key intersection point, at which the
metabolic signals of circulating glucose level, and hormonal cues
meet. Glucose uptake increases the cellular ATP:ADP ratio, and
eventually leads to increased intracellular Ca
2+ concentration via
closure of ATP-sensitive K
+ channels and opening of voltage-gated
L-type Ca
2+ channels [53]. Ca
2+ influx initiated by glucose
stimulation activates Ca
2+-calmodulin-dependent protein kinase,
whereas cAMP signals triggered by hormonal cues or forskolin
activate cAMP-dependent proteinase A (PKA). These Ser/Thr
kinases phosphorylate CREB at Ser133 and promote transactiva-
tory potential [10]. In the present study, acute challenges with
15 mM glucose or 30 mM forskolin are equally effective in
prolonging ICER induction in pancreatic islet cells. However,
the differential effects of glucose and forskolin on insulin secretion
is also possible since insulin secretion is a complex consequence
resulted from glucose transport/sensing, insulin synthesis/expres-
sion, membrane depolarization, and insulin exocytosis [54–56].
The differential effects of glucose and forskolin on insulin secretion
maybe partially ascribed to the fact that glucose influences all these
processes while forskolin mainly regulates the insulin expression
with CREB-dependent pathways [25,57]. Recent studies have
shown that although CREB activity is potentiated by PKA, CREB
phosphorylation alone is not a reliable predictor of target gene
activation, and additional CREB regulatory partners such as such
CREB binding protein (CBP) and cAMP-regulated transcriptional
co-activator2 (CRTC2) are required for recruitment of the
transcriptional apparatus to the promoter [10,58]. Thus, multiple
regulatory pathways triggered by circulating glucose and hormon-
al cues converge on the CREB activity in pancreatic b-cells via
CREB phosphorylation and dephosphorylation at Ser133, CBP,
and CRTC2 binding, and competition with ICER.
ICER has been identified in a variety of brain regions, including
the cerebral cortex, the hippocampus, hypothalamic nuclei,
dentate gyrus, and cerebellum [59] where NeuroD is also
expressed [60,61]. Notably, NeuroD contributes to the develop-
ment of neuronal cells [38], exocytotic processes [43], and synaptic
maturation [62]. Therefore, constant silencing of NeuroD by
ICER may facilitate progression of the neuropathological defects
that occur as diabetic complications. Interestingly, diabetes
mellitus and reduced PP2A activity have been implicated as risk
factors for Alzheimer’s disease, although the molecular links are
yet to be fully clarified [63–65]. Given that NeuroD and ICER
play essential roles in neurons and neuroendocrine cells, the
present study provides novel insights into the potential common
25 mM glucose after stimulation with 30 mM forskolin for the indicated time. Long-term culture in 25 mM glucose enhanced the binding of ICER to
CRE (right panels). The absence of immunoprecipitated CRE with a nonspecific IgG verified the specificity of the assay. Results from three
independent ChIP assays were semi-quantitatively measured and presented as fold ratios with respect to the value obtained without forskolin in
5.5 mM glucose. Significant effects of forskolin (*, P,0.05; **, P,0.01) or chronic high glucose (
#, P,0.05) are marked.
doi:10.1371/journal.pone.0034860.g004
Figure 5. Chronic hyperglycemia persistently activates the
basal and forskolin-stimulated pCREB. (A)H I Tc e l l sw e r e
incubated in the presence of 30 mM forskolin for the indicated time
before harvesting. Western blot analysis was carried out with an
antibody specific for CREB phosphorylated at Ser133 (pCREB). The
membrane was re-probed with an anti-CREB antibody to determine the
total amount of CREB. (B) Levels of pCREB were normalized to that of
total CREB. Data from three independent western assays are presented
as the fold ratios with respect to the value of HIT cells grown in 5.5 mM
glucose in the absence of forskolin. Significant effects of forskolin
(*, P,0.05; **, P,0.01) or chronic high glucose (
#, P,0.05) are marked.
doi:10.1371/journal.pone.0034860.g005
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34860Figure 6. Chronic hyperglycemia reduces the PP2A level. (A, B) Rat islet cells grown in 5 mM or 30 mM glucose were treated with 30 mM
forskolin for 6 h (the same conditions as shown in Figure 2A). Alternatively rat islet cells grown in 5 mM or 30 mM glucose for 8 days were stimulated
with 15 mM glucose for the indicated times (the same conditions as shown in Figure 1A). RT-PCR analysis was employed to determine the relative
PP1a, PP2A Ca, and calcineurin/PP2B-Aa mRNA levels. The average values of PP2A Ca from three independent experiments are presented in the
bottom of the gel as the relative ratios to the basal expression value in 5 mM glucose. (C, D) Western analysis performed with HIT cells grown in
5.5 mM or 25 mM glucose. PP1, PP2A, and PP2B level was normalized to that of actin. The average values from three independent experiments are
presented in each lane as the relative ratio to the basal expression level in 5.5 mM glucose. (E) HIT cell lysates were immunoprecipitated with anti-
PP2A antibody and subject to a standard phosphatase assay with a synthetic peptide. Data from three independent experiments are presented as
fold ratios with respect to the value obtained in 5.5 mM glucose (**, P,0.01). (F) HIT cells grown in 25 mM glucose were cotransfected with 0.4 mg
NeuroD reporter gene and 0.15 mg CREB expression vector, together with indicated amount of the PP2A Ca expression vector. Forskolin was added
to a final concentration of 30 mM for 6 hour. The relative luciferase activity from three independent experiments is presented as the fold ratio with
respect to the value of reporter gene alone (*, P,0.05; **, P,0.01).
doi:10.1371/journal.pone.0034860.g006
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PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e34860processes by which chronic hyperglycemia accompanies not only
b-cell dysfunction but also diabetic neuropathy.
In conclusion, a decrease in Ser/Thr phosphatase activity under
conditions of chronic hyperglycemia is one of important process
for gradual depletion of insulin reservoir during the progression of
b-cell dysfunction. Interruption of the vicious cycle (Figure 8)
triggered by the reduced phosphatase and the consequent ICER-
mediated repression of NeuroD may be of clinical value in
preventing b-cell failure and glucotoxicity in patients with Type 2
diabetes.
Materials and Methods
Ethics Statements
The Animal Care Committee of the Catholic University of
South Korea approved the experimental protocol by the
Institutional Animal and Use Committee (IACUC No. 2009-
0093-04), and all procedures performed in this study were followed
by ethical guidelines for animal studies.
Plasmids
The reporter plasmids used in this study containing the
proximal promoter regions of NeuroD, including pGL3-Neu-
roD(22.2 kb) and pGL3-NeuroD(2100 bp) have been described
previously by Huang et al., 2000 [34]; an CREB expression vector
by Ghil et al., 2000 [66]; expression vectors for CREMta and
ICER Ic by Inada et al., 1999 [25]; the catalytic subunit of PP2B-
Aa/calcinurin by Oliveria et al., 2003 [67]. Expression vectors for
PP1 and PP2A were generated by inserting the coding region of
each catalytic subunit into the pLenti M1.4-MCMV (Macrogen,
Seoul, South Korea) ; PP2A Ca (gi: 13277983) with BamHI and
ClaI, PP1a (gi: 133892519) with XbaI and ClaI. The CRE site
within the 1,025 bp fragment of the NeuroD promoter was
mutagenized through multiple steps of PCR using Taq polymerase
(Roche, Mannheim, Germany) and finally inserted to pGL3-
NeuroD(22.2 kb) that was digested with NheI and XhoI. The
224 bp fragment with mCRE was inserted into Kpn1 and Nco1
site to replace the wild type CRE in pGL3-NeuroD(2100 bp).
Pancreatic islet cells
Rat pancreatic islets were isolated from Sprague-Dawley rats
(200–230 g) by digesting the pancreatic duct with 1 mg/ml
collagenase P (Roche) in phosphate buffered saline (PBS) and
separated with Histopaque-1077 (Sigma, St. Louis, MO) as
previously described [68]. The islets with similar sizes (100–
150 mm) were hand-picked under a dissecting microscope and
incubated in PRMI 1640 (Invitrogen, Carlsbad, CA) containing
1,800 mg/l (10 mM) glucose, 10% FBS, 100 unit/ml penicillin,
100 mg/ml streptomycine in uncoated petridish for 24 h. Then
islets were divided into two groups and preconditioned for 8 days
either in RPMI 1640 with 10% fetal bovine serum (FBS)
containing 900 mg/l glucose (5 mM, low/normal level) or
5400 mg/l glucose (30 mM, high level) at 37uC under 5% CO2
atmosphere. During this period, medium was replaced with fresh
one every other day. Before RT-PCR analysis, the islet cells from
each group were pre-conditioned in fresh RPMI with 10% FBS
containing 900 mg/l (5 mM) glucose for 2 h at 37uC and then
transferred to fresh RPMI 1640 containing 15 mM glucose
(Figure 1A). After incubation for the indicated period of time,
total RNA was isolated and subject to SYBR green real-time or
semi-quantitative RT-PCR. Alternatively, after pre-incubation in
the presence of 5 mM glucose for 2 h, the islet cells were
transferred to fresh RPMI 1640 containing 5 mM or 30 mM
glucose and then, forskolin (Sigma) was added to a final
concentration of 30 mM (Figure 2A) to avoid the pleiotropic
effects of GLP-1 on b-cells [69] and directly activate adenylyl
cyclase to increase the intracellular levels of cAMP. As shown in
Figure 3 and Supporting Figure S4, both 30 mM forskolin and
10 mM forskolin persistently induced the ICER expression in HIT
cells after long-term cultivation in the presence of 25 mM glucose.
The similar results with 10 mM and 30 mM forskolin suggest that
our original data obtained with 30 mM forskolin are reliable.
Therefore, we utilized 30 mM forskolin throughout our experi-
ments. The homogeneity and the viability of islets were verified
with dithizone (DTZ) staining in the presence of 5 mM or 30 mM
glucose (Figure 1B). Briefly, pancreatic islets were incubated in
RPMI 1640 medium containing 0.1 mg/ml DTZ (Sigma) for
5 min at room temperature. Islets were stained crimson red to
determine homogeneity and viability of islets.
Figure 7. Reduced activity of PP2A is the primary cause of impaired gene expression. (A) HIT cells were transfected with the indicated
amounts of PP2A Ca siRNA for 48 h. RNA was harvested and subjected to RT-PCR analysis or proteins subject to western analysis. Scrambled RNA was
employed to validate the specificity of PP2A Ca-specific siRNA. (B) HIT cells grown in 5.5 mM glucose were transfected with 50 nM siRNA specific for
PP2A Ca or with scrambled sequences. Prior to harvesting, 30 mM forskolin was added to the culture for 1–6 h. Western analysis was performed with
anti-phospho CREB (pCREB Ser133) or PP2A Ca antibody, followed by antibody against total CREB. (C) RT-PCR analysis with HIT cells grown in 5.5 mM
glucose indicated that PP2A Ca-specific siRNA altered the basal and forskolin-induced gene expression of ICER, NeuroD, SUR1, and insulin as shown in
hyperglycemic conditions. (E) RT-PCR analysis with HIT cells stably overexpressing PP2A Ca. Overexpression of PP2A in HIT cells grown in 25 mM
glucose restored the ICER, NeuroD, SUR1, and insulin to the values obtained in normoglycemic (5.5 mM) condition. (D, F) Data from three
independent experiments shown in C, E are presented as fold ratios with respect to the value of scrambled siRNA or mock-transfected HIT cells
(
#, P,0.05;
##, P,0.05), and to the value of without forskolin (*, P,0.05; **, P,0.01).
Figure 8. ICER-mediated NeuroD repression aggravates vicious
cycle of chronic hyperglycemia. In normoglycemia, PP2A keeps the
level of CREB below the physiological threshold and transient activation
of CREB in response to glucose and incretin is not sufficient to induce
persistent expression of ICER. In chronic hyperglycemia, CREB is
constantly activated due to the decreased PP2A level. Upon glucose
stimulation or hormonal cues, CREB is further activated for an extended
period of time, leading to prolonged ICER induction. Consequently,
excessively produced ICER proteins repress the NeuroD expression and
the NeuroD’s target genes including insulin, SUR1, and components of
the exocytotic machinery. The hyperglycemic condition is progressively
aggravated through this vicious negative cycle of insulin depletion, and
ultimately progressed to b-cell failure. (a) Inada et al., 1999 [25];
Abderrahmani et al., 2006 [28]; (b) Naya et al., 1995 [4]; (c) Kim et al.,
2002 [5]; (d) Ishizuka et al., 2007 [43], Gu et al., 2010 [7]; (e) Sassone-
Corsi, 1998 [24]; and (f) this study. The active pathways in chronic
hyperglycemia are presented as solid (—) lines, while the defective
pathway as dashed (----) lines. Arrows indicate stimulatory effects, while
blunt ends inhibitory effects.
doi:10.1371/journal.pone.0034860.g008
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Isolated rat islets incubated under low glucose (5 mM) and
hyperglycemic (30 mM) conditions for 8 days were washed in
KRB washing buffer (130 mM NaCl, 3.6 mM KCl, 1.5 mM
CaCl2, 0.5 mM MgSO4, 0.5 mM KH2PO4, 2.0 mM NaHCO3,
and 10 mM Hepes, pH 7.4) and incubated in KRB buffer
containing 5 mM glucose at 37uC for 2 h. Then, 30 islets with
similar sizes were stimulated with 15 mM glucose in 1 ml KRB
buffer at 37uC and the KRB buffer was collected 6 h later for
quantification of secreted insulin with radioimmunoassay (RIA) kit
(Linco, St. Charles, MO). The islets were harvested and total
intracellular insulin content were extracted by incubating them
overnight in 1% hydrochloric acid (ethanol/H2O2/HCl, 14:57:3)
at 4uC. After sonication and centrifugation, 200 ml of the
supernatant was used for RIA to determine the intracellular
insulin content and 800 ml for Bradford assay to determine the
total proteins.
HIT-T15 cell culture
HIT-T15 cells (hamster insulinoma tumor cells) from American
Type Culture Collection (Cat. No. CRL-1777, ATCC, Manassas,
VA 20108,) were grown in DMEM (Invitrogen) with 10% FBS
containing 990 mg/l (5.5 mM, low/normal level) or 4,500 mg/l
(25 mM, high level) glucose for at least two weeks. To stably
overexpress PP2A Ca, HIT cells were transfected with a PP2A Ca
expression vector and selected in the presence of 10 mg/ml
puromycin (Sigma) for 2 weeks.
Reporter gene assay
One day prior to transfection, HIT cells were plated at a density
of 3610
5 cells per well in 6-well plates. Transfection was carried
out with indicated amount of reporter plasmids and expression
vectors using Lipofectamine Plus (Invitrogen), following the
manufacturer’s recommendations. The day after transfection, the
medium was replaced with fresh growth medium containing 0.5%
FBS, and cell growth continued for 24 h. Forty hours after
transfection, forskolin was added at a final concentration of 30 mM
for the indicated time-period before harvesting cells. Luciferase
activity was determined with cell extracts using the Dual-
Luciferase assay system (Promega, Madison, WI). During
transfection, the total DNA amount was kept constant by adding
pcDNA3 (Invitrogen). A plasmid for Renilla LUC-thymidine
kinase (Promega) was used as an internal control to normalize
transfection efficiency. Normalized luciferase activity was present-
ed as a fold ratio in relation to the basal activity of the reporter
gene in the absence of expression vectors or forskolin.
Quantitative real-time PCR and semi-quantitative RT-PCR
analysis
Isolated rat islets or HIT cells were incubated under low glucose
and high glucose conditions as mentioned above. Then, total RNA
was isolated from cells using RNAzol B (Tel-Test, Friendswood,
TX), and cDNA synthesized from 1 mg of RNA using the First-
strand cDNA synthesis kit (Roche). Two ml of reaction product
from reverse transcription for first-strand cDNA was used for
SYBR green quantitative real-time PCR for islets using a Rotor-
gene Q, Qiagen Thermal-cycler equipment (Qiagen, Valencia,
CA) and power SYBRH Green PCR master mix (Applied
Biosystems, Foster city, CA). Primers for NeuroD, ICER I,
SUR1, Insulin I/II in SYBR green real-time PCR were designed
to recognize the separate exons of both rat and hamster genes to
exclude the possibility of amplifying genomic DNA (Supporting
Table S1). The PCR conditions for each set of primers were as
follows: after initial denaturation at 95uC for 10 min, 40 cycles of
denaturation at 95uC for 15 sec, annealing at indicated temper-
ature for 30 sec, and extension at 72uC for 40 sec (Supporting
Table S1). Following the final amplification cycle, a melting curve
was acquired by one cycle of heating at 72uC for 1 min, and then
increasing the temperature to 95uC at a rate of 1uC per min. The
specificity of PCR reaction was ensured by single peak in melting
curve analysis. The original values of cycle threshold (Ct) are
described in Supporting Table S3. The results were normalized to
the expression levels of the GAPDH reference gene and the
relative mRNA levels were calculated using the 2
2DDCt method
[70]. The data represent means 6 S.E. of three independent
experiments, expressed as fold ratio of mRNA expression
compared with the control value (islets cultivated in 5 mM glucose
without 15 mM glucose stimulus in Figure 1 or 30 mM forskolin
treatment in Figures 2). Each experiment was carried out in
duplicates. Traditional, semi-quantitative RT-PCR was also
carried out with the same sets of primers for NeuroD, SUR1,
insulin, pdx-1, PP1a, PP2B-Aa, and PP2A Ca and GAPDH
except ICER (Supporting Table S1). The ICER-specific primer set
could detect two splice variants, ICER I and ICER Ic. PCR was
performed with an initial denaturation at 98uC for 1 min; 30
cycles for each genes comprising 95uC for 1 min, annealing at the
indicated temperature for 30 sec, and extension at 72uC for 1 min;
and a final extension at 72uC for 7 min. PCR products were
separated by electrophoresis on 2% agarose gels. Signals from
traditional RT-PCR results were captured with a VersaDoc 4000
Imager (Bio-Rad Laboratories, Hercules, CA) and normalized to
the value of GAPDH. PCR with 28,32 cycles yielded similar
extent of amplification (Supporting Figure S1), indicating the PCR
reaction was not saturated. The results were also similar to those
obtained with SYBR green real-time PCR (compare Figure 1D–H
with Supporting Figure S1), suggesting the reliability of our
traditional, semi-quantitative RT-PCR data performed with HIT
cells.
Western blot analysis
Cells were lysed in RIPA buffer (50 mM Tris; pH 7.4, 1 M
NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% sodium dodecyl
sulphate) using a standard protocol and subjectect to polyacryl
amide gel electrophoresis. After transferred to PVDF membrane,
the protein was identified with the primary antibodies: phospho-
CREB (1:1000, polyclonal, Cell Signaling, Danvers, MA), catalytic
subunits of PP1a, PP2B-Aa, and PP2A Ca (1:1000, monoclonal,
Upstate, Temecula, CA). Immunoreactivity was visualized using
horse radish peroxidase-conjugated anti-rabbit or mouse IgG
antibodies (1:5000, Zymed, San Francisco, CA) and the Super-
Signal Chemiluminescence Substrate kit (PIERCE, Rockford, IL).
To confirm equal loading, blots were stripped and reprobed with
antibodies against CREB (1:1000, Cell Signaling) or a-actin
(1:1000, Sigma).
Chromatin immunoprecipitation (ChIP) assay
HIT cells (1.5610
6/100 mm dish) were incubated in 1% (v/v)
formaldehyde, lysed, and subjected to immunoprecipitation with
1 mg of anti-ICER antibody (SantaCruz Biotechnology Inc., Santa
Cruz, CA). ICER-bound DNA was precipitated using a ChIP
assay kit (Upstate), following the manufacturer’s recommendation,
and resuspended in 20 mlo fH 2O. Amplification was conducted
with 2 ml DNA solution under the following conditions: initial
denaturation at 98uC for 1 min, 35 cycles of 94uC for 1 min, 52uC
for 40 sec, and 72uC for 1 min, and a final extension step at 72uC
for 7 min. The PCR primers designed for amplifying the proximal
NeuroD promoter were 59-aaagttctggggaggggtgaatgag-39 (2160/
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reverse). The 189 bp PCR product was analyzed on a 2% agarose
gel.
PP2A activity assay
HIT cells (3610
5/35 mm dish) were harvested in phosphatase
extraction buffer (100 mM Tris-HCI, pH 7.6, 2 mM MgCl2,
1 mM CaCl2, 2 mM EGTA, 2 mM EDTA, 1% Triton X-100,
1 mM PMSF, protease inhibitor cocktail). After sonification, the
clear lysates were precleared with 50% (w/v) protein A Sepharose
bead (Amersham, Little Chalfont, Buckinghamshire, UK) and
then incubated with 4 mg of antibody against the catalytic subunit
of PP2A Ca (Upstate). After washing with PBS, the remaining
activity in immunoprecipitates was assessed using a Ser/Thr
phosphatase assay kit (Upstate) with 0.75 mM synthetic PP2A-
specific phosphopeptide (K-R-pT-I-R-R) as a substrate for 10 min
at 30uC. Free phosphate in a 25 ml reaction volume was
colorimetrically measured at 650 nm after reaction with malachite
green as recommended by the manufacturer. Specific activity of
phosphatase (pmoles of phosphate/min/mg protein) was deter-
mined by comparing with controls containing no enzyme or a
freshly prepared phosphate standard. The data from three
independent experiments are presented as the mean 6 S.E. with
respect to the value in the presence of 5 mM glucose.
Preperation of PP2A siRNA and transfection
HIT cells were transfected with 50 nM siRNA for silencing
PP2A Ca (59-tggaacttgacgacactcttaa-39) or scrambled siRNA
(Genolution, Seoul, South Korea), using Lipofectamine RNAi
MAX (Invitrogen). The following day, the medium was replaced
with fresh DMEM (5.5 mM glucose) containing 0.5% FBS, and
cell growth continued for 24 h. Silencing or overexpression of
PP2A was verified by RT-PCR and western analysis (Figure 7A).
Statistical analysis
Signals from western blot, RT-PCR and ChIP analysis were
captured with a VersaDoc 4000 Imager (Bio-Rad Laboratories).
All experiments were conducted a minimum of 3 times, and data
presented as means 6 S.E. P values for statistical significance were
estimated with respect to the indicated control value using the t test
(*
/#, P,0.05; **
/##, P,0.01).
Supporting Information
Figure S1 The effects of chronic hyperglycemia on b-cell
specific genes in rat islets were analyzed using semi-
quantitative RT-PCR. (A) The mRNA levels of indicated genes
in various conditions as shown in Figure 1A were also analyzed
using traditional, semi-quantitative RT-PCR analyses. Two
isoforms of ICER I (168 bp) and its splice variant, ICER Ic
(129 bp) were identified with the same set of primers, while non-
allelic Ins 1 and Ins 2 were detected as s single band (Supporting
Table S1). The effects of chronic hyperglycemia on gene
expression were similar when PCR was carried out for 28,32
cycles, suggesting that there was no saturation of the PCR
amplification or ethidium-bromide staining. (B) RT-PCR results
from amplification for 30 cycles were semi-quantitatively mea-
sured and normalized to that of GAPDH. Data from three
independent experiments are presented as average fold ratios with
respect to the value of 5 mM glucose-cultured islets before glucose
stimulation. The overall effects of chronic hyperglycemia on gene
expression were similar to the results obtained with SYBR green
real-time PCR as shown in Figure 1, verifying that the semi-
quantitative RT-PCR data in the subsequent studies with HIT
cells were also reliable to demonstrate the relative mRNA level.
Significant effects of 15 mM glucose (*, P,0.05; **, P,0.01) or 8-
day incubation in 30 mM glucose (
#, P,0.05) were marked.
(TIF)
Figure S2 The effects of chronic hyperglycemia on the
responsiveness to forskolin in rat islets were analyzed
using semi-quantitative RT-PCR. (A) Semi-quantitative RT-
PCR from islet cells cultured in various conditions as shown in
Figure 2A also represents the chronic effect of hyperglycemia on
the expression of ICER, NeuroD, SUR1, and insulin gene. (B)
RT-PCR results from amplification for 30 cycles were semi-
quantitatively measured and normalized to that of GAPDH. Data
from three independent experiments are presented as average fold
ratios with respect to the value of 5 mM glucose-cultured islets
prior to addition of forskolin. The overall effects of chronic
hyperglycemia on the responsiveness to forskolin were similar to
the results obtained with SYBR green real-time PCR as shown in
Figure 2, verifying that the semi-quantitative RT-PCR data from
HIT cells in the present study were also reliable to demonstrate the
relative mRNA level. Significant effects of forskolin (*, P,0.05;
**, P,0.01) or 8-day incubation in 30 mM glucose (
#, P,0.05)
were marked.
(TIF)
Figure S3 Cloning of hamster PP2A Ca. The hamster PP2A
Ca cDNA was cloned (gi:325504919) in this study. The sequence
analysis indicated 97.5% identity at the DNA level and 99.97%
identity at the protein level among the mammals. Nucleotide
sequences used for siRNA are marked with the solid-line and the
primers used for RT-PCR analysis are marked with dotted lines.
(TIF)
Figure S4 To validate the effectiveness of 30 mM for-
skolin. To avoid the pleiotropic effects of GLP-1 on b-cells and
directly activate adenylyl cyclase to increase the intracellular levels
of cAMP, we utilized 30 mM forskolin throughout our experi-
ments. As shown in Figure 3 with 30 mM forskolin, 10 mM
forskolin also persistently induced the ICER expression in HIT
cells after long-term cultivation in the presence of 25 mM glucose.
The similar results with 10 mM and 30 mM forskolin suggest that
our original data obtained with 30 mM forskolin are reliable.
(TIF)
Table S1 Experimental conditions for SYBR green real-
time PCR and traditional RT-PCR. Both rat (r) and hamster
(h) gene specific primers for NeuroD, ICER I, SUR1, Insulin I/II,
PP1a, CaN, and PP2A Ca were designed to recognize the
separate exons to exclude the possibility of amplifying contami-
nating genomic DNA. Blast analysis showed high sequence
homology for each gene between rodents and mammals ranging
from 92 to 98%. The GenBank numbers for rat and hamster
sequences were used to design the common primers for semi-
quantitative RT-PCR and SYBR green real-time PCR except for
the ICER gene. The ICER-specific primers recognized two
isoforms, ICER I (168 bp), and its splice variant, ICER Ic (129 bp)
in traditional, semi-quantitative RT-PCR. However, this primer
set interfered with real-time amplification, thus we designed a new
primer for SYBR green real-time PCR which only recognized
ICER I but not lacking domain called c in ICER Ic. For the
insulin genes, two nonallelic genes (insulin I and II) displaying
more than 90% homology [71,72] were detected as a 308 bp
product with the same set of primers.
(TIF)
Table S2 CRE-like sequences are conserved at the
proximal promoter region of NeuroD. In the mouse
ICER-Mediated NeuroD Repression in Hyperglycemia
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transcription initiation site, which is 43 bp upstream of the TATA
box. The CRE-like sequence (TCAGCT
C/A
A/G) is highly
conserved among humans, primates and rodents, suggesting
functional significance through evolution.
(TIF)
Table S3 Ct mean values from SYBR green real-time
RT-PCR of b-cell specific genes expressed in pancreatic
rat islets. Rat pancreatic islet cells were cultured in the presence
of 5 mM or 30 mM glucose for 8 days before being challenged
with 15 mM glucose or 30 mM forskolin (Figure 1A and 2A).
Quantitative real time RT-PCR was carried out using SYBR
green. Each experiment was carried out in duplicates and the
mean values of cycle threshold (Ct) from three independent
experiments were presented as means 6 S.E. These Ct values
were used to deduce relative mRNA levels using the 2
2DDCt
method. The relative mRNA level of each gene was normalized to
the value of GAPDH and presented as a fold ratio with respect to
the control value (non-glucose or forskolin treated-islet cells under
conditions of 5 mM glucose) in Figure 1 and 2.
(TIF)
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